European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim (EMA press release, 23 September 2010)

Introduction to the News Media event for scientists

Call to 'suspend' diabetes drug (BBC News, 23 September 2010)

23 Sept 2010

The European Medicines Agency has recommended that marketing authorisation for the diabetes drug Avandia (generic name rosiglitazone) be suspended following a review of data on the drug's cardiovascular side-effects.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read